Innovation1 Biotech Inc Revenue Growth Rates (MYYZ), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Innovation1 Biotech Inc   (MYYZ)
 

MYYZ's Revenue Growth by Quarter and Year

Innovation1 Biotech Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYYZ Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter August -
3rd Quarter May -
2nd Quarter February 0.00
1st Quarter November 0.00
FY 0.00

MYYZs Annual Revenue
Innovation1 Biotech Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Innovation1 Biotech Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Innovation1 Biotech Inc 's Revenue in the fiscal year 2021 $ 0.00 millions
Innovation1 Biotech Inc 's Revenue in the fiscal year 2020 $ 0.00 millions
Innovation1 Biotech Inc 's Revenue in the fiscal year 2019 $ 0.08 millions




MYYZ Revenue second quarter 2024 Y/Y Growth Comment
Innovation1 Biotech Inc in the second quarter 2024 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2024, Innovation1 Biotech Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Innovation1 Biotech Inc ' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2024.


MYYZ Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter August - - - -
3rd Quarter May - - - -
2nd Quarter February - - - -
1st Quarter November - - - -
FY   - - - -

Financial Statements
Innovation1 Biotech Inc 's second quarter 2024 Revenue $ 0.00 millions MYYZ's Income Statement
Innovation1 Biotech Inc 's second quarter 2023 Revenue $ 0.00 millions Quarterly MYYZ's Income Statement


MYYZ Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter August - - - -
3rd Quarter May - - - -
2nd Quarter February - - - -
1st Quarter November - - - -
FY (Year on Year)   - - - -


Back to MYYZ Growth rate Comparisons >> Back to MYYZ Growth rate Comparisons >>


Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Innovation1 Biotech Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MYYZ's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MYYZ's II. Quarter Q/Q Revenue Comment


Innovation1 Biotech Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Feb 29 2024)		 12 Months Ending
(Nov 30 2023)		 12 Months Ending
(Aug 31 2023)		 12 Months Ending
(May 31 2023)		 12 Months Ending
(Feb 28 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Feb 29 2024 period, Innovation1 Biotech Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Innovation1 Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Feb 29 2024 period, Innovation1 Biotech Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Innovation1 Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MYYZ's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Feb 29 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Feb 29 2024
Angiodynamics Inc -7.25%$ -7.249 millions
Biomerica Inc -8.50%$ -8.497 millions


About Innovation1 Biotech Inc Revenue Growth Rates (MYYZ), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Innovation1 Biotech Inc (CIK 1629205).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001753926-25-000753
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Innovation1 Biotech Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.